EU drug chiefs hit out at ‘excessive cosmetic use’ of jabs like Ozempic that’s causing shortages with ‘serious consequences for public health’

European Medicines Agency (EMA) bosses now say their use among non-obese patients who ‘do not have weight related health problems’ has ‘raised concerns’.European Medicines Agency (EMA) bosses now say their use among non-obese patients who ‘do not have weight related health problems’ has ‘raised concerns’.Read MoreHealth News | Mail Online